MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
Volume 4.70M
Average 0.95M
Returns on capital
MiniMed Group, Inc. Common Stock management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-9.2%
avg -5.0%
ROIC
1.2%
avg -1.6%
ROA
-7.1%
avg -4.0%
Analysis
ROIC is currently the strongest return metric at 1.2% versus its period average of -1.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Chad J. Spooner | Executive VP & CFO | USD 5.82M | 54 | — | — |
Que Thanh Dallara | CEO & Director | USD 1.86M | 52 | — | — |
Ali Dianaty | Executive VP and Chief Product & Technology Officer | USD 1.56M | 51 | 325.82K | 0.12% |
Gillian Chandrasena | Senior VP & Chief Human Resources Officer | USD 1.32M | 52 | 174.54K | 0.06% |
Courtney Nelson Wills | Senior VP, General Counsel & Corporate Secretary | USD 850.19K | 50 | 136.38K | 0.05% |
Sheila A. Denton | Senior VP, General Counsel & Corporate Secretary | USD 850.19K | 60 | 58.94K | 0.02% |
Kate Cronin | SVP and Chief Marketing & Communications Officer | — | 60 | — | — |
Mike Bruggeman | SVP & Chief Information Officer | — | — | — | — |
Ryan Weispfenning | Head of Investor Relations | — | — | — | — |
Slobodan Radumilo | SVP & Chief Commercial Officer of EMEA and APAC | — | 55 | — | — |
Yael Glassman | SVP, Chief Strategy & Corporate Development Officer | — | — | — | — |
Christopher E. Eso | President | — | — | — | — |
John Gyurci | VP, Chief Accounting Officer & Controller | — | 55 | 39.94K | 0.01% |
Compensation is shown in the reported currency; data updated Nov 18, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 28, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +11.4% | +8.1% (6yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | +24.3% (6yr)3 analysts |
Analysis
Recent growth has been strongest in Revenue at +11.4% over three years. Forward estimates point to EBIT at +24.3% (6yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does MiniMed Group, Inc. Common Stock compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about MMED's management, answered from reported figures.
Who manages MMED?
MiniMed Group, Inc. Common Stock (MMED) lists 13 active executives. The top listed executive is Courtney Nelson Wills, Senior VP, General Counsel & Corporate Secretary.
Are MMED insiders buying or selling?
Recent insider activity shows net buying of $9.78M.
Continue the stock analysis
Jump to another research area for this company.